Skip to content

TIPP Staff

FDA Approves Moderna's First mRNA Flu Vaccine

FDA Approves Moderna's First mRNA Flu Vaccine

In a clinical study involving 40,000 adults aged 50 to 64, Moderna's vaccine reduced influenza cases by approximately 27 percent. The FDA also granted accelerated approval for adults aged 65 and older.

Members Public
Get The Flock Out

Get The Flock Out

Earlier this year, the Charlottesville City Council discontinued its one-year pilot program with Flock Safety after concerns about data protection, potential misuse, and limits on local control.

Members Public